Ignite Creation Date:
2024-05-06 @ 7:19 PM
Last Modification Date:
2024-10-26 @ 3:04 PM
Study NCT ID:
NCT05964673
Status:
RECRUITING
Last Update Posted:
2023-08-30
First Post:
2023-07-18
Brief Title:
Effect of Bioptron Light Therapy on Dryness of Eyes in Postmenopausal Women
Sponsor:
Cairo University
Organization:
Cairo University
Study Overview
Official Title:
Effect of Bioptron Light Therapy on Dryness of Eyes in Postmenopausal Women
Status:
RECRUITING
Status Verified Date:
2023-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Dry eye disease DED is a growing public health concern affecting quality of life and visual function with a significant socio-economic impact It is more prevalent in the females and is being specifically in the menopausal and postmenopausal age group
Bioptron light therapy is efficient in the elimination of allergic reactions signs and symptoms of dry eye improving capillary circulation immunity stimulation relieving pain and establishing balance of tissue electromagnetic field
Bioptron light therapy is efficient in the elimination of allergic reactions signs and symptoms of dry eye improving capillary circulation immunity stimulation relieving pain and establishing balance of tissue electromagnetic field
Detailed Description:
Around 60 postmenopausal women will be randomly divided into two equal groups they all complain from dry eye symptoms ranging from mildnormal to moderate and severe
GroupA will receive patient education program for four weeks GroupB will receive patient education program and bioptron light therapy for four weeks
GroupA will receive patient education program for four weeks GroupB will receive patient education program and bioptron light therapy for four weeks
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
True
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?:
None